Introduction: Yangling Jinhai Biotechnology Co., Ltd. (hereinafter referred to as "Yangling Jinhai") is a designated production enterprise approved by the Ministry of Agriculture. It is jointly funded and established by Shanghai Lihai Biotechnology Co., Ltd. (hereinafter referred to as "Lihai Biotechnology") and Argentina BiogénesisBagó S.A (hereinafter referred to as "BAGO Company"), and adopts the current international advanced suspension culture technology and concentration and purification technology to produce high-purity inactivated foot-and-mouth disease vaccine. Relying on shareholders' financial advantages, management advantages and technical advantages, Yangling Jinhai introduced the most advanced foot-and-mouth disease vaccine manufacturing technology into China. The construction project of foot-and-mouth disease vaccine production base invested by Yangling Jinhai with 300 million yuan started on 20 14, and the products are expected to be listed at the end of 20 16. After the project is put into production, it will be realized
Legal Representative: Zhang Haiming.
Establishment time: 20 13-02- 16.
Registered capital: RMB100000 yuan.
Industrial and commercial registration number: 610403100015375.
Type of enterprise: limited liability company (Sino-foreign joint venture)
Company address: No.31Donghuan North Road, Yangling Demonstration Zone, Shaanxi Province